Hepatocyte growth factor prevents lipopolysaccharide-induced hepatic sinusoidal endothelial cell injury and intrasinusoidal fibrin deposition in rats

Journal of Surgical Research

Volumn 80, Issue 2, 1998, Pages 194-199

  Seto, Shin Ichi ^a   Kaido, Toshimi ^a   Yamaoka, Shoji ^a   Yoshikawa, Akira ^a   Arii, Shigeki ^a   Nakamura, Toshio ^a   Niwano, Mototaka ^a   Imamura, Masayuki ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Fibrin deposition; HGF; Lipopolysaccharide; Microcirculation; Sinusoidal endothelial cell

Indexed keywords

AMINOTRANSFERASE; FIBRIN; HYALURONIC ACID; LIPOPOLYSACCHARIDE; RECOMBINANT SCATTER FACTOR;

ANIMAL CELL; ARTICLE; CELL DAMAGE; CELL PROTECTION; CELL ULTRASTRUCTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; FIBRIN DEPOSITION; LIVER PROTECTION; LIVER SINUSOID; MALE; MICROCIRCULATION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0032447694     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1998.5472     Document Type: Article

References (46)

1. Hewett J. A., Roth R. A. Hepatic and extrahepatic pathobiology of bacterial lipopolysaccharides. Pharm. Rev. 45:1993;381.
2. Edwards M. J., Heniford B. T., Miller F. N. Tumor necrosis factor mediates disseminated intravascular inflammation in the genesis of multiple organ edema. J. Surg. Res. 54:1993;140.
3. Mathison J. C., Ulevich R. J. The clearance, tissue distribution and cellular localization of iv injected LPS in rabbits. J. Immunol. 123:1979;2133.
4. Ruiter D. J., Van der Meulen J., Brouwer A., Hummel M. J. R., Mauw B. J., Van der Ploeg J. C. M., Wisse E. Uptake by liver cells of endotoxin following its intravenous injection. Lab. Invest. 45:1981;38.
5. Praaning-Van Dalen D. P., Brouwer A., Knook D. L. Clearance capacity of rat liver Kupffer, endothelial and parenchymal cells. Gastroenterology. 81:1981;1036.
6. Sultzer B. M. Genetic control of leukocyte response to endotoxin. Nature. 219:1968;1253.
7. Wahl L. M., Rosenstreich D. L., Glode L. M., Sandberg A. L., Mergenhagen S. E. Defective prostaglandin synthesis by C3H/Hej mouse macrophages stimulated with endotoxin preparations. Infect. Immun. 23:1979.
8. Beutler B., Krochin N., Milsark I. N., Luedke C., Cerami A. Control of cachectin (tumor necrosis factor) synthesis: Mechanisms of endotoxin resistance. Science. 232:1986;977.
9. Kurokawa S., Ishibashi H., Shirahama M., Hayashida K., Tuchiya Y., Sakai Y. Production of hepatocyte stimulating factor of rat Kupffer cells induced by lipopolysacchride: Partial characterization and effects on alpha 2 macroglobulin gene expression in cultured adult rat hepatocytes. J. Clin. Lab. Immunol. 25:1988;131.
10. Chensue S. W., Terbuh P. D., Remick D. G., Scales W. E., Kunkel S. L. In vivo biologic and immunohistochemical analysis of interleukin-1alpha and tumor necrosis factor during experimental endotoxemia. Am. J. Pathol. 138:1991;395.
11. Catell J. V., Andus T., Kunz D., Heinrich P. C. Interleukin-6: The major regulator of acute-phase protein synthesis in man and rat. Ann. N. Y. Acad. Sci. 557:1989;87.
12. Arthur M. J., Bentley I. S., Tanner A. R., Sauders P. K., Millward-Sandler G. H., Wright R. Oxygen-derived free radicals promote hepatic injury in the rat. Gastroenterology. 89:1985;1114.
13. Kuiper J., Casteleyn E., Van Berkel T. J. Regulation of liver metabolism by intercellular communication. Adv. Enzyme Regul. 27:1988;193.
14. Fraser J. R., Alcorn D., Laurent T. C., Robinson A.D., Ryan G. B. Uptake of circulating hyaluronic acid by the rat liver. in situ. Cell Tissue Res. 242:1985;505.
15. Deaciue I. V., Bagby G. J., Lang C. H., Skrepnic N., Spitzer J.J. Gram-negative bacteria lipopolysaccharide impairs hyaluronan clearancein vivo. Hepatology. 18:1993;173.
16. Bottaro D. P., Rubin J. S. D., Deaciuc I. V., Bagby G. J., Niesman M. R., Skrepnic N., Spitzer J. J. Modulation of hepatic sinusoidal endothelial cell function by Kupffer cells: An example of intercellular communication in the liver. Hepatology. 19:1994;464.
17. Sarphie T. G., D'Souza N. B., Deaciuc I. V. Kupffer cell inactivation prevents lipopolysaccharide-induced structural changes in the rat liver sinusoid: An electron microscopic study. Hepatology. 23:1996;788.
18. Hirata K., Ogata I., Ohta Y., Fujiwara K. Hepatic sinusoidal cell destruction in the development of intravascular coagulation in acute liver failure of rats. J. Pathol. 158:1989;157.
19. Levy E., Path F. C., Ruebner B. H. Hepatic changes produced by single dose of endotoxin in the mouse. Am. J. Pathol. 51:1967;269.
20. Margaretten W., McKey D. G., Phllips L. L. The effect of heparin on endotoxin shock in the rat. Am. J. Pathol. 51:1967;61.
21. Prager R. L., Dunn E. L., Kirsh M. M., Penner J. A. Endotoxin-induced intravascular coagulation and its therapy. Adv. Shock Res. 2:1979;277.
22. Shibayama Y. Sinusoidal circulatory disturbance by microthrombosis as a cause of endotoxin-induced hepatic injury. J. Pathol. 151:1987;314.
23. Hewett J. A., Roth R. A. The coagulation system, but not circulating fibrinogen, contributes to liver injury in rats exposed to lipopolysaccharide from gram-negative bacteria. J. Phamacol. Exp. Ther. 272:1955;53.
24. Fujiwara K., Ogata I., Ohta Y., Hirata K., Oka Y., Yamada S., Sato Y., Maski H., Oka H. Intravascular coagulation in acute liver failure in rats and its treatment with antithrombin III. Gut. 29:1988;1103.
25. Coalson J. J. Pathology of sepsis, septic shock, and multiple organ failure. Perspective on Sepsis and Septic Shock. 1986;27.
26. Matsumoto K., Nakamura T. Hepatocyte growth factor: Molecular structure, roles in liver regeneration and other biological functions. Crit. Rev. Oncog. 3:1992;37.
27. Rubin J. S., Bottaro D. P., Aaronson S. A. Hepatocyte growth factor and its receptor, the c-met protooncogene product. Biochim. Biophy. Acta. 1155:1993;357.
28. Michalopoulous G. K., Zamegav R. Hepatocyte growth factor. Hepatology. 15:1992;149.
29. Rubin J. S., Chan A. M., Bottaro D. P., Burgess W. H., Taylor W. G., Cech A. C., Hirshfield D. W., Wong J., Miki T., Finch P. W., Aaronson S. A. A broad-spectrum human lung fibroblast-derived mitogen is a varant of hepatocyte growth factor. Proc. Natl. Acad. Sci. USA. 88:1991;415.
30. Grant D. S., Kleinman H. K., Goldberg I. D., Bhargava M. M., Nickoloff B. J., Kinsella J. L., Polverini P., Rosen E. M. Scatter factor induces blood vessel formationin vivo. Proc. Natl. Acad. Sci. USA. 90:1993;1937.
31. Rosen E. M., Goldberg I. D. Scatter factor and angiogenesis. Adv. Cancer Res. 67:1995;257.
32. Kaido T., Yamaoka S., Seto S., Tanaka J., Nakamura T., Imamura M. Continuous hepatocyte growth factor supply prevents lipopolysaccharide-induced liver injury in rats. FEBS Lett. 411:1997;378.
33. Matsuda Y., Matsumoto K., Ichida T., Nakamura T. Hepatocyte growth factor suppresses the onset of liver cirrhosis and abrogates lethal hepatic dysfunction in rats. J. Biochem. Tokyo. 118:1995;643.
34. Butler W. H., Hard G. C. Hepatotoxic of dimethylnitrosamine in rat with special reference to veno-occulusive disease. Exp. Mol. Pathol. 15:1971;209.
35. Baker S. J., Markowitz S., Fearon E. R., Willson J. K., Vogelstein B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science. 249:1990;912.
36. Topp W. C. Normal rat cell lines deficient in nuclear thymidine kinase. Virology. 113:1981;408.
37. Graham F. L., Van der Eb A. J. Transformation of rat cells by DNA of human adenovirus. Virology. 54:1973;536.
38. 4. Biochem. Biophys. Res. Commun. 218:1996.
39. Frenzel H., Kremer B., Hucher H. The liver sinusoids under various pathological conditions. Kupffer Cells and Other Sinusoidal Cells. 1977;213.
40. Moore K. L., Andrcoli S. P., Esmon N. L., Esmon C. T., Bang N. U. Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endotheliumin vitro. J. Clin. Invest. 79:1987;124.
41. Pober J. S., Cotran R. Cytokines and endothelial cell biology. Physiol. Rev. 70:1990;427.
42. Archipoff G., Beretz A., Freyssinet J. M., Klein-Soyer C., Brisson C., Cazenave J. P. Heterogeneous regulation of constitutive thrombomodulin or inducible tissue factor activates on the surface of human saphenous-vein endothelial cells in culture following stimulation by interleukin-1, tumor necrosis factor, thrombin or phorbol ester. Biochem. J. 273:1991;679.
43. Schleef R. R., Bevilacqua M. P., Sawdey M., Gimbrone M. A. Jr., Lskutoff D. J. Cytokine activation of vascular endothelium: Effect on tissue-type plasminogen activator inhibitor. J. Biol. Chem. 263:1988;5797.
44. Iimuro Y., Yamamoto M., Kohno H., Itakura J., Fujii H., Matsumoto Y. Blockade of liver macrophages by gadolinium chloride reduces lethality in endotoxemic rats - Analysis of mechanisms of lethality in endotoxemia. J. Leukocyte Biol. 55:1994;723.
45. Ishiki Y., Ohnishi H., Muto Y., Matsumoto K., Nakamura T. Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent anti-hepatitis effectin vivo. Hepatology. 16:1992;1227.
46. Amicone L., Spagnoli F. M., Spath G., Bernadini S., DeLuca V., Rocca C. D., Weiss M. C., Comoglio P. M., Tripodi M. Transgenic expression in the liver of truncated Met blocks apoptosis and permits immortalization of hepatocytes. EMBO J. 16:1997;495.